Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447635 · ClinicalTrials.gov registry record · NA
Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT07447635: Recruiting NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT07447635 is a NA study that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07447635, a NA study, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.
Primary Outcome
Self-reported no combustible tobacco use in the past 7 days, verified with saliva cotinine \<10 ng/mL.
Interventions
- BEHAVIORAL Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA)
- BEHAVIORAL Quitline Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2026-05-15 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT07447635 shows while recruiting
NCT07447635 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) is the first listed.
NCT07447635 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07447635 about?
NCT07447635 is a clinical study titled "Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors". This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder i...
What is the current status of trial NCT07447635?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2026-05-15. Estimated completion is 2029-12.
What interventions are being tested in trial NCT07447635?
The interventions under investigation include: Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) (BEHAVIORAL), Quitline Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT07447635?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07447635's enrollment target sits among peer trials
600 162nd of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI